These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
779 related articles for article (PubMed ID: 29858962)
1. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Karaosmanoğlu O; Banerjee S; Sivas H Cell Oncol (Dordr); 2018 Aug; 41(4):439-453. PubMed ID: 29858962 [TBL] [Abstract][Full Text] [Related]
2. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition. Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058 [TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
4. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma. Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103 [TBL] [Abstract][Full Text] [Related]
5. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma. Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761 [TBL] [Abstract][Full Text] [Related]
7. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma. Xiao H; Jiang N; Zhou B; Liu Q; Du C Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189 [TBL] [Abstract][Full Text] [Related]
8. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Jin Y; Wang J; Han J; Luo D; Sun Z Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482 [TBL] [Abstract][Full Text] [Related]
10. Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma. Lien HC; Yu HC; Yu WH; Lin SF; Chen TW; Chen IC; Hsiao LP; Yeh LC; Li YC; Lo C; Lu YS Breast Cancer Res; 2024 Sep; 26(1):130. PubMed ID: 39256881 [TBL] [Abstract][Full Text] [Related]
11. [Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression]. Balcik-Ercin P; Cetin M; Yalim-Camci I; Uygur T; Yagci T Mol Biol (Mosk); 2020; 54(1):87-94. PubMed ID: 32163392 [TBL] [Abstract][Full Text] [Related]
12. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells. Yang L; Chang Y; Cao P Exp Cell Res; 2018 Oct; 371(1):231-237. PubMed ID: 30107147 [TBL] [Abstract][Full Text] [Related]
13. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Deng G; Zeng S; Ma J; Zhang Y; Qu Y; Han Y; Yin L; Cai C; Guo C; Shen H Sci Rep; 2017 Jan; 7():41616. PubMed ID: 28134289 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of UBAP2L Inhibits the Epithelial-Mesenchymal Transition via SNAIL1 Regulation in Hepatocellular Carcinoma Cells. Ye T; Xu J; Du L; Mo W; Liang Y; Xia J Cell Physiol Biochem; 2017; 41(4):1584-1595. PubMed ID: 28334716 [TBL] [Abstract][Full Text] [Related]
15. Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients. Verneuil L; Leboeuf C; Bousquet G; Brugiere C; Elbouchtaoui M; Plassa LF; Peraldi MN; Lebbé C; Ratajczak P; Janin A Oncotarget; 2015 Dec; 6(39):41497-507. PubMed ID: 26594799 [TBL] [Abstract][Full Text] [Related]
16. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug. Wu J; Ru NY; Zhang Y; Li Y; Wei D; Ren Z; Huang XF; Chen ZN; Bian H Oncogene; 2011 Oct; 30(43):4410-27. PubMed ID: 21532623 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus x protein induces epithelial-mesenchymal transition of hepatocellular carcinoma cells by regulating long non-coding RNA. Jin Y; Wu D; Yang W; Weng M; Li Y; Wang X; Zhang X; Jin X; Wang T Virol J; 2017 Dec; 14(1):238. PubMed ID: 29258558 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
19. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma. Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858 [TBL] [Abstract][Full Text] [Related]
20. Krüppel-like factor 4, a tumor suppressor in hepatocellular carcinoma cells reverts epithelial mesenchymal transition by suppressing slug expression. Lin ZS; Chu HC; Yen YC; Lewis BC; Chen YW PLoS One; 2012; 7(8):e43593. PubMed ID: 22937066 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]